Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Martin

Showing results (101-110 of 133) with videos related to

Pageof 14
Sort By:
Immunology Letters|January 11, 2025
Post hoc analysis: 6 Months immunogenicity after third dose of BNT162b2 vs JNJ-78,436,735 after two doses of BNT162b2 vaccine in solid organ transplant recipientsYoichiro Natori, Eric Martin, Adela Mattiazzi, et al.
JCO Global Oncology|October 29, 2021
Spotlight on International Quality: COVID-19 and Its Impact on Quality Improvement in Cancer CareDouglas W Blayney, Giovanni Bariani, Devika Das, et al.
Journal of the National Cancer Institute|September 24, 2014
Test of four colon cancer risk-scores in formalin fixed paraffin embedded microarray gene expression dataAntonio F Di Narzo, Sabine Tejpar, Simona Rossi, et al.
Retrovirology|June 3, 2014
Switching and emergence of CTL epitopes in HIV-1 infectionChungyong Han, Ai Kawana-Tachikawa, Akihisa Shimizu, et al.
Scientific Reports|November 7, 2013
Structure of TCR and antigen complexes at an immunodominant CTL epitope in HIV-1 infectionAkihisa Shimizu, Ai Kawana-Tachikawa, Atsushi Yamagata, et al.
Plos One|September 10, 2013
No evidence for selection of HIV-1 with enhanced gag-protease or Nef function among breakthrough infections in the CAPRISA 004 tenofovir microbicide trialDenis R Chopera, Jaclyn K Mann, Philip Mwimanzi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 4, 2024
The Irreversible FGFR Inhibitor KIN-3248 Overcomes FGFR2 Kinase Domain MutationsEranga R Balasooriya, Qibiao Wu, Haley Ellis, et al.
JCO Oncology Practice|July 21, 2025
Oncology Medical Homes: ASCO-Community Oncology Alliance StandardsKim Woofter, Erin B Kennedy, Kerin Adelson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2011
Primary CNS lymphoma in children and adolescents: a descriptive analysis from the International Primary CNS Lymphoma Collaborative Group (IPCG)Oussama Abla, Sheila Weitzman, Jean-Yves Blay, et al.
Haematologica|December 3, 2011
A Cancer and Leukemia Group B multi-center study of DA-EPOCH-rituximab in untreated diffuse large B-cell lymphoma with analysis of outcome by molecular subtypeWyndham H Wilson, Sin-Ho Jung, Pierluigi Porcu, et al.
Pageof 14

Showing results (101-110 of 133) with videos related to

Sort By:
Pageof 14
Immunology Letters|January 11, 2025
Post hoc analysis: 6 Months immunogenicity after third dose of BNT162b2 vs JNJ-78,436,735 after two doses of BNT162b2 vaccine in solid organ transplant recipientsYoichiro Natori, Eric Martin, Adela Mattiazzi, et al.
JCO Global Oncology|October 29, 2021
Spotlight on International Quality: COVID-19 and Its Impact on Quality Improvement in Cancer CareDouglas W Blayney, Giovanni Bariani, Devika Das, et al.
Journal of the National Cancer Institute|September 24, 2014
Test of four colon cancer risk-scores in formalin fixed paraffin embedded microarray gene expression dataAntonio F Di Narzo, Sabine Tejpar, Simona Rossi, et al.
Retrovirology|June 3, 2014
Switching and emergence of CTL epitopes in HIV-1 infectionChungyong Han, Ai Kawana-Tachikawa, Akihisa Shimizu, et al.
Scientific Reports|November 7, 2013
Structure of TCR and antigen complexes at an immunodominant CTL epitope in HIV-1 infectionAkihisa Shimizu, Ai Kawana-Tachikawa, Atsushi Yamagata, et al.
Plos One|September 10, 2013
No evidence for selection of HIV-1 with enhanced gag-protease or Nef function among breakthrough infections in the CAPRISA 004 tenofovir microbicide trialDenis R Chopera, Jaclyn K Mann, Philip Mwimanzi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 4, 2024
The Irreversible FGFR Inhibitor KIN-3248 Overcomes FGFR2 Kinase Domain MutationsEranga R Balasooriya, Qibiao Wu, Haley Ellis, et al.
JCO Oncology Practice|July 21, 2025
Oncology Medical Homes: ASCO-Community Oncology Alliance StandardsKim Woofter, Erin B Kennedy, Kerin Adelson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2011
Primary CNS lymphoma in children and adolescents: a descriptive analysis from the International Primary CNS Lymphoma Collaborative Group (IPCG)Oussama Abla, Sheila Weitzman, Jean-Yves Blay, et al.
Haematologica|December 3, 2011
A Cancer and Leukemia Group B multi-center study of DA-EPOCH-rituximab in untreated diffuse large B-cell lymphoma with analysis of outcome by molecular subtypeWyndham H Wilson, Sin-Ho Jung, Pierluigi Porcu, et al.
Pageof 14